Molecular mechanisms in toxicology will be illustrated using examples based on the use of new approach methodologies (NAMs) including in vitro methods and omics tools which can be applied for understanding mechanisms of toxicity and provide data for physiological based pharmacokinetic modelling as well as for understanding population dynamics and individual susceptibility. This will be constructed into toxicological molecular evolution of events by fitting them into Adverse Outcome Pathways (AOPs) which are now beginning to be applied in risk assessment workflows.
The course will be an integration of lectures and assignments. The assignments will be centred around adverse outcome pathway development.